Celldex Therapeutics reported $692.41M in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
AbbVie USD 136.17B 1B Mar/2025
Amgen USD 87.9B 1.47B Jun/2025
Bristol-Myers Squibb USD 94.68B 2.25B Jun/2025
Celldex Therapeutics USD 692.41M 47.06M Jun/2025
Glaxosmithkline GBP 59.26B 205M Jun/2025
Pfizer USD 206.1B 1.93B Jun/2025
Roche Holding CHF 101.8B 6.02B Dec/2024